Biotech NewsCalciMedica (CALC) Advances Phase 2 Trial for Acute Kidney Injury BioTech Health XNovember 25, 2025 CalciMedica Inc. (NASDAQ:CALC) is a clinical-stage biopharmaceutical company built on over a decade of pioneering research in calcium… 0 Shares 0 0 0 0 0 0 0